학술논문

Engineered nanomicelles inhibit the tumour progression via abrogating the prostaglandin-mediated immunosuppression
Document Type
Article
Source
In: Journal of Controlled Release. (Journal of Controlled Release, April 2024, 368:548-565)
Subject
Language
English
ISSN
18734995
01683659